Sign in

CIK 0001818844

  • Non-accelerated filer
  • Smaller reporting company

Dogwood Therapeutics, Inc.

Sign in to watch
Ticker
DWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
854314201
Phone
+1 866-620-8655
Business address
44 MILTON AVENUE, ALPHARETTA, GA, 30009
Former names
Virios Therapeutics, Inc., Virios Therapeutics, LLC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy SVP OF FINANCE bought 2,000 shares at $4.58 ($9,150)
  7. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 7,500 shares at $4.52 ($33,900)
  8. 4 Open-market buy Director bought 500 shares at $4.53 ($2,263)
  9. 4 Open-market buy Director bought 241 shares at $4.50 ($1,085)
  10. 4 Open-market buy Director bought 13,450 shares at $4.38 ($58,914)
  11. 4 Open-market buy Director bought 600 shares at $4.94 ($2,964)
  12. 4 Open-market buy Director bought 2,197 shares at $5.46 ($12,002)
  13. 5 Insider Annual Insider Trading Report
  14. 4 Open-market buy Director bought 4,180 shares at $5.98 ($24,998)
  15. 4 Open-market buy Director bought 4,000 shares at $5.90 ($23,584)
  16. 4 Open-market buy Director bought 1,800 shares at $5.72 ($10,296)
  17. 4 Open-market buy Director bought 5,000 shares at $5.80 ($28,975)
  18. 4 Open-market buy Director bought 2,215 shares at $5.43 ($12,034)
  19. 4 Open-market buy Director bought 1,000 shares at $5.65 ($5,650)
  20. 4 Open-market buy Director bought 200 shares at $5.73 ($1,145)

Page 4 of 6 · 117 filings